Literature DB >> 12590976

Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules.

Catherine Menier1, Berta Saez, Vaclav Horejsi, Silvia Martinozzi, Irene Krawice-Radanne, Sylvie Bruel, Caroline Le Danff, Murielle Reboul, Ivan Hilgert, Michèle Rabreau, Mur Luis Larrad, Marika Pla, Edgardo D Carosella, Nathalie Rouas-Freiss.   

Abstract

Nonclassical major histocompatibility complex (MHC) class I human leukocyte antigen E (HLA-E) and HLA-G molecules differ from classical ones by specific patterns of transcription, protein expression, and immunotolerant functions. The HLA-G molecule can be expressed as four membrane-bound (HLA-G1 to -G4) and three soluble (HLA-G5 to -G7) proteins upon alternative splicing of its primary transcript. In this study, we describe a new set of monoclonal antibodies (mAbs) called MEM-G/01, -G/04, -G/09, -G/13, MEM-E/02, and -E/06 recognizing HLA-G or HLA-E. The pattern of reactivity of these mAbs were analyzed on transfected cells by flow cytometry, Western blotting, and immunochemistry. MEM-G/09 and -G/13 mAbs react exclusively with native HLA-G1 molecules, as the 87G mAb. MEM-G/01 recognizes (similar to the 4H84 mAb) the denatured HLA-G heavy chain of all isoforms, whereas MEM-G/04 recognizes selectively denatured HLA-G1, -G2, and -G5 isoforms. MEM-E/02 and -E/06 mAbs bind the denatured and cell surface HLA-E molecules, respectively. These mAbs were then used to analyze the expression of HLA-G and HLA-E on freshly isolated cytotrophoblast cells, on the JEG-3 placental tumor cell line, and on cryopreserved and paraffin-embedded serial sections of trophoblast tissue. These new mAbs represent valuable tools to study the expression of HLA-G and HLA-E molecules in cells and tissues under normal and pathologic conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12590976     DOI: 10.1016/s0198-8859(02)00821-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  37 in total

1.  Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.

Authors:  Susan E Hiby; Richard Apps; Andrew M Sharkey; Lydia E Farrell; Lucy Gardner; Arend Mulder; Frans H Claas; James J Walker; Christopher W Redman; Christopher C Redman; Linda Morgan; Clare Tower; Lesley Regan; Gudrun E Moore; Mary Carrington; Ashley Moffett
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

2.  Application of cryo-compatible antibodies to human placenta paraffin sections.

Authors:  Astrid Blaschitz; Martin Gauster; Gottfried Dohr
Journal:  Histochem Cell Biol       Date:  2008-06-18       Impact factor: 4.304

3.  Modulation of HLA-G expression in human neural cells after neurotropic viral infections.

Authors:  Monique Lafon; Christophe Prehaud; Françoise Megret; Mireille Lafage; Gaël Mouillot; Michèle Roa; Philippe Moreau; Nathalie Rouas-Freiss; Edgardo D Carosella
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes.

Authors:  Marloes Gooden; Margit Lampen; Ekaterina S Jordanova; Ninke Leffers; J Baptist Trimbos; Sjoerd H van der Burg; Hans Nijman; Thorbald van Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

5.  The HLA-G genotype is associated with IL-10 levels in activated PBMCs.

Authors:  Roberta Rizzo; Thomas Vauvert F Hviid; Marina Stignani; Alessandra Balboni; Maria Teresa Grappa; Loredana Melchiorri; Olavio R Baricordi
Journal:  Immunogenetics       Date:  2005-04-02       Impact factor: 2.846

6.  Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells.

Authors:  Elisa Lo Monaco; Elisa Tremante; Cristina Cerboni; Elisa Melucci; Leonardo Sibilio; Alessandra Zingoni; Maria Rita Nicotra; Pier Giorgio Natali; Patrizio Giacomini
Journal:  Neoplasia       Date:  2011-09       Impact factor: 5.715

7.  Non-classical MHC-E (Mamu-E) expression in the rhesus monkey placenta.

Authors:  S V Dambaeva; G I Bondarenko; R L Grendell; R H Kravitz; M Durning; T G Golos
Journal:  Placenta       Date:  2007-11-09       Impact factor: 3.481

8.  In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner.

Authors:  Philippe Rousseau; Krzysztof Masternak; Michal Krawczyk; Walter Reith; Jean Dausset; Edgardo D Carosella; Philippe Moreau
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

9.  HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms.

Authors:  Thomas Vauvert F Hviid; Roberta Rizzo; Ole B Christiansen; Loredana Melchiorri; Anette Lindhard; Olavio R Baricordi
Journal:  Immunogenetics       Date:  2004-05-07       Impact factor: 2.846

10.  Immunomodulatory molecules are released from the first trimester and term placenta via exosomes.

Authors:  S K Kshirsagar; S M Alam; S Jasti; H Hodes; T Nauser; M Gilliam; C Billstrand; J S Hunt; M G Petroff
Journal:  Placenta       Date:  2012-10-26       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.